Fundraising Fox
/People
Sign in

Abasi Ene-Obong

InvestorFounder

Founder at 54Gene

United States

Founded54Gene · YC

Find your path to Abasi

11,861 people in our graph can introduce you to Abasi.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Jay Parrish to introduce you to Abasi

You →Jay · together at Gilead Sciences (2013–2014) →Abasi

Ask Jamie Chen to introduce you to Abasi

You →Jamie · 2 people · together at IMS Health →Abasi

Ask Sam Okafor to introduce you to Abasi

You →Sam · 9 people · together at YC W19 →Abasi

Sign up to find every way you can get introduced to Abasi

  • Your email: the people you already email who know Abasi
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Abasi
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Abasi Ene-Obong is the founder and CEO of Syndicate Bio, a health technology company developing diverse human health datasets and applying AI/ML to health research and care. He previously founded and served as CEO of 54gene, an African genomics company where he built a biobank of over 100,000 consented samples linked to clinical records, and worked as a management consultant at IQVIA and PwC advising pharmaceutical companies. He holds a PhD in Cancer Biology from the University of London, an MSc in Human Molecular Genetics from Imperial College London, and a business master's from the Keck Graduate Institute, and has been published in journals including Cell, Nature, and Cancer Discovery.

Founder at 54GeneYC W19

Intro paths

YC

Abasi went through Y Combinator (Winter 2019) — any YC alum in your network can reach them through the YC community.

→

In turn, Abasi can intro founders to 54Gene's investors below.

54Gene's investors · 22

Adjuvant CapitalNew York · $10M – $25M checks · since 2020Aera VCSingapore · $25K – $5M checksBetter Ventures Central LlcOakland · $500K – $1.5M checksEndeavor CatalystNew YorkFifty YearsSan Francisco · $250K – $2M checksFor Good VenturesFuture AfricaLagos · $100K – $500K checksHack VCPalo Alto · $3M checksIngressive CapitalLagos · $500K checksKairos AngelsKdT VenturesAustin · $500K – $3M checksLead Edge CapitalNew York · $50M – $400M checks · since 2021OurCrowdJerusalemPioneerToronto, OntarioPlexo CapitalSan Francisco · $10K – $5M checksSamsung NextSan Jose · $100K – $5M checksThe Raba PartnershipCape Town · $50K – $5M checksV8 Capital PartnersLagosVenture Investment AssociatesPeapackWamda CapitalDubaiWellington ManagementBoston · $5M – $50M checksY CombinatorSan Francisco · $500K checks · since 2019

Co-founders at 54Gene

GAGatumi Aliyu
Gatumi AliyuFounder
OFOgochukwu Francis Osifo
Ogochukwu Francis OsifoFounder

Experience

  1. Syndicate BioFounder and CEOcurrent2023 — present
  2. ACMG - American College of Medical Genetics and GenomicsMember, International Outreach and Engagement Committeecurrent2024 — present
  3. Society for Family Health NigeriaMember Board of Trusteescurrent2022 — present
  4. BloombergMember, Bloomberg New Economy Forum International Cancer Coalitioncurrent2022 — present
  5. 54geneFounder and CEO2019 — 2022
  6. Pathfinder InternationalLead Consultant (state) - Nigeria's Strategic Health Development Plan2017Nigeria
  7. PwCSenior Associate, Health Industries Advisory2015 — 2016Greater Chicago Area
  8. IMS HealthConsultant2014 — 2015Greater Philadelphia
  9. IMS HealthResearch Manager, IMS Institute for Healthcare Informatics2014
  10. Gilead SciencesConsultant2013 — 2014Los Angeles Metropolitan Area
  11. PanasonicStrategy Consultant2013
  12. Barts Cancer InstituteDoctoral Researcher2010 — 2013London Area, United Kingdom
  13. Institute of Psychiatry, King's College LondonHonorary Research Associate2009 — 2010London Area, United Kingdom

Skills & more

Startups8Life Sciences31Business Development10Molecular Biology29Entrepreneurship13Genetics7Marketing Strategy7Market Research7Project Management6Cancer7Consulting5Genomics5
+12 moreDrug DiscoveryManagement ConsultingBusiness StrategyBusiness Process DesignMedical DevicesProduct DevelopmentMarketing ManagementProduct marketingStrategyManagementLeadershipPharmaceutical Industry

Languages English · French · Igbo

From Abasi's professional profile.

Investments

Investor

DailyDoctor

Per curated public sources.

Frequently asked questions

Who is Abasi Ene-Obong?
Abasi Ene-Obong is the founder and CEO of Syndicate Bio, a health technology company developing diverse human health datasets and applying AI/ML to health research and care. He previously founded and served as CEO of 54gene, an African genomics company where he built a biobank of over 100,000 consented samples linked to clinical records, and worked as a management consultant at IQVIA and PwC advising pharmaceutical companies. He holds a PhD in Cancer Biology from the University of London, an MSc in Human Molecular Genetics from Imperial College London, and a business master's from the Keck Graduate Institute, and has been published in journals including Cell, Nature, and Cancer Discovery.
Where does Abasi Ene-Obong work?
Abasi Ene-Obong is Founder of 54Gene.
What companies did Abasi Ene-Obong found?
Abasi Ene-Obong founded 54Gene.
What companies has Abasi Ene-Obong invested in?
Investments tracked here include DailyDoctor.
Where did Abasi Ene-Obong go to school?
Abasi Ene-Obong studied at Imperial College London (Master of Science (M.Sc.); DIC, Human Molecular Genetics); Keck Graduate Institute (Masters of Business and Management, Bioscience management); University of London (PhD- Barts and the London School of Medicine and Dentistry, Cancer Biology).

Founder mafias

Same school

Shared employers

Also worked at Pathfinder International1

Priya AgrawalMSD at i3 — Investing in Innovation Africa